An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group (Q71192246)
Jump to navigation
Jump to search
scientific article published on 01 July 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group |
scientific article published on 01 July 1996 |
Statements
An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group (English)
Pneumocystis carinii
1 reference
R A McIvor
P Berger
L L Pack
A Rachlis